2026-04-29T12:23:06Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/237062024-11-28T21:38:35Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967
Repisalud
author
Parvanova, Aneliya
author
Abbate, Manuela
author
Yañez, Aina M
author
Bennasar-Veny, Miquel
author
López-González, Angel Arturo
author
Ramírez-Manent, José Ignacio
author
Iliev, Ilian Petrov
author
Fresneda, Sergio
author
Arias-Fernández, María
author
Remuzzi, Giuseppe
author
Ruggenenti, Piero
2024-10-09T06:35:10Z
2024-10-09T06:35:10Z
2023-05-23
Parvanova A, Abbate M, Yañez AM, Bennasar-Veny M, López-González ÁA, Ramírez-Manent JI, et al. MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and preserved kidney function: A cross-sectional study. Diabetes Res Clin Pract. 2023 May 23;201:110729.
10.1016/j.diabres.2023.110729
1872-8227
Diabetes research and clinical practice
https://hdl.handle.net/20.500.13003/18992
37230296
L2024693682
2-s2.0-85160266340
https://hdl.handle.net/20.500.12105/23706
1013316700001
Aims: To investigate the prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) in prediabetes, visceral obesity, and preserved kidney function, and explore whether MAFLD is associated with hyperfiltration. Methods: We analyzed data from 6697 Spanish civil servants, aged 18-65 years, with fasting plasma glucose ≥ 100 and ≤ 125 mg/dL (prediabetes, ADA), waist circumference ≥ 94 cm in men and ≥ 80 cm in women (visceral obesity, IDF) and de-indexed estimated glomerular filtration rate (eGFR) ≥ 60 ml/min, collected during occupational health visits. The association between MAFLD and hyperfiltration (eGFR > age- and sex-specific 95th percentile) was tested by multivariable logistic regression analyses. Results: Overall, 4213 patients (62.9%) had MAFLD, and 330 (4.9%) were hyperfiltering. MAFLD was more frequent in hyperfiltering than in non-hyperfiltering subjects (86.4% vs 61.7%, P < 0.001). BMI, waist circumference, systolic, diastolic, mean arterial pressure, and prevalence of hypertension were higher in hyperfiltering than in non-hyperfiltering subjects (P < 0.05). MAFLD was independently associated with hyperfiltration, even after adjusting for common confounders [OR (95% CI): 3.36 (2.33-4.84), P < 0.001]. In stratified analyses MAFLD potentiated age-related eGFR decline vs. non-MAFLD (P < 0.001). Conclusions: More than half of subjects with prediabetes, visceral obesity and eGFR ≥ 60 ml/min presented MAFLD that was associated with hyperfiltration and potentiated the age-related eGFR decline.
eng
MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and "preserved" kidney function: A cross-sectional study
research article